Loading
LOADING
Looking for the honest take. Phase 2 data is impressive but limited. Phase 3 readouts are 1-2 years out. Compound is available now through research channels.
Is it worth waiting for the larger trial confirmation, or is the Phase 2 evidence strong enough that delayed adoption costs you what you'd save in confirmation certainty?
No comments yet. Start the thread.